Evidence map›Paper›PMID 38463963›Full record

ArticlebioRxiv : the preprint server for biology2024

Distinct

Mark G Young, Timothy J Straub, Colin J Worby, Hayden C Metsky, Andreas Gnirke, Ryan A Bronson, Lucas R van Dijk, Christopher A Desjardins, Christian Matranga, James Qu and 8 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Mark G YoungInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0009-0001-4111-9329
Timothy J StraubInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0001-5009-0778
Colin J WorbyInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0002-9132-7249
Hayden C MetskyInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0002-8871-2349
Andreas GnirkeInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0001-5324-6387
Ryan A BronsonInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.
Lucas R van DijkInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0002-7565-5859
Christopher A DesjardinsInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0002-3160-4734
Christian MatrangaInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.
James QuInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.
Jesús Bazan VillicanaDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-8724-3213
Philippe AzimzadehDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Andrew KauDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-9386-3766
Karen W DodsonDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-7421-9660
Henry L SchreiberDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-4501-9886
Abigail L MansonInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0002-3800-0714
Scott J HultgrenDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Ashlee M EarlInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.ORCID 0000-0001-7857-9145
Broad Institute · USWashington University in St. Louis · US

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
Epidemiologic and molecular basis of the gut-urinary tract axis in urinary tract infectionR01DK121822 · NIDDK · WASHINGTON UNIVERSITY · PI Ashlee Miriam Earl, SCOTT J. HULTGREN · 2020 to 2026
$4.9M
Harnessing Antibody Responses to Prevent and Treat Urinary Tract InfectionsR01AI165915 · NIAID · WASHINGTON UNIVERSITY · PI Andrew Leon Kau · 2022 to 2026
$3.1M
NIAID NIH HHS R01 AI165915NIAID NIH HHS U19 AI110818NIDDK NIH HHS R01 DK121822
6 · The paper itself

Abstract

Low-abundance members of microbial communities are difficult to study in their native habitats. This includes

Identifiers

PMID38463963
PMCPMC10925322
OpenAlexW4392397692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.